| | |
David M. Anderson, D.V.M.
Executive Director, Health Sciences Administration
Institutional Official, UW Animal Care and Research Program
Clinical Associate Professor, Department of Comparative Medicine
University of Washington
P: (206) 543-7202 / (206) 543-7938
F: (206) 543-3473
David Anderson is a laboratory animal veterinarian and pathologist who holds the position of Director of the Washington National Primate Research Center. Dr. Anderson's research has focused on issues related to non-human primate models of AIDS with special emphasis on the neuropathology associated with the mechanisms of pathogenesis of the disease. Dr. Anderson has served as attending veterinarian for non-human primates at the WaNPRC, providing multiple opportunities to serve as a resource and colleague for faculty, staff and post-doctoral fellows from the department of Comparative Medicine.
Hukkanen RR, Liggitt HD, Kelley ST, Grant R, Anderson DM, Hall RA, Tesh RB, Travassos DaRosa AP, Bielefeldt-Ohmann H. (2006). West Nile and St. Louis encephalitis virus antibody seroconversion, prevalence, and persistence in naturally infected pig-tailed macaques (Macaca nemestrina). Clin Vaccine Immunol. Jun;13(6):711-4.
Hukkanen RR, Liggitt HD, Kelley ST, Grant R, Anderson DM. (2006). Detection of systemic amyloidosis in the pig-tailed macaque (Macaca nemestrina). Comp Med. Apr;56(2):119-27.
Kinman LM, Worlein JM, Leigh J, Bielefeldt-Ohmann H, Anderson DM, Hu S-L, Morton WR, Anderson BD, Ho RJY (2004) HIV in central nervous system and behavioral development- an HIV-2 287 macaque model of AIDS. AIDS18(10):1363-1370.
Locher C, S.A. Witt, B.M. Ashlock, P. Polacino, S-L.Hu, S. Shiboski, A. M. Schmidt, M. B. Agy, D. M. Anderson, , S. Staprans, and J. A. Levy. (2004). Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection. Vaccine 22:2261-2272.
Doria-Rose NA, Ohlen C, Polacino P, Pierce CC, Hensel MT, Kuller L, Mulvania T, Anderson D, Greenberg PD, Hu S-L, Haigwood NL (2003) Multi-gene DNA prime-boost vaccines protect macaques from acute CD4+ T cell depletion after SHIV89.6P mucosal challenge. J Virol 77:11563-577.